Research output per year
Research output per year
Personal profile
Headline
ASSISTANT PROFESSOR | Urology
Fingerprint
Dive into the research topics where John Sfakianos is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A multidisciplinary discussion of BladderPath
St-Laurent, M. P., Sfakianos, J. P., Rose, T. L., Chung, P., Kassouf, W., Zlotta, A. R., Inman, B. & Black, P. C., Mar 2024, In: Canadian Urological Association Journal. 18, 3Research output: Contribution to journal › Comment/debate
Open Access -
Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial(Nature Medicine, 10.1038/s41591-023-02568-1)
Galsky, M. D., Daneshmand, S., Izadmehr, S., Gonzalez-Kozlova, E., Chan, K. G., Lewis, S., Achkar, B. E., Dorff, T. B., Cetnar, J. P., Neil, B. O., D’Souza, A., Mamtani, R., Kyriakopoulos, C., Jun, T., Gogerly-Moragoda, M., Brody, R., Xie, H., Nie, K., Kelly, G. & Horowitz, A. & 20 others, , Apr 2024, In: Nature Medicine. 30, 4, p. 1211 1 p.Research output: Contribution to journal › Comment/debate
Open Access1 Scopus citations -
BCG and Alternative Therapies to BCG Therapy for Non-Muscle-Invasive Bladder Cancer
Lidagoster, S., Ben-David, R., De Leon, B. & Sfakianos, J. P., Feb 2024, In: Current Oncology. 31, 2, p. 1063-1078 16 p.Research output: Contribution to journal › Review article › peer-review
Open Access2 Scopus citations -
Clinical Implications of Basic Research: Exploring the Transformative Potential of Spatial 'Omics in Uro-oncology
Figiel, S., Bates, A., Braun, D. A., Eapen, R., Eckstein, M., Manley, B. J., Milowsky, M. I., Mitchell, T. J., Bryant, R. J., Sfakianos, J. P. & Lamb, A. D., 2024, (Accepted/In press) In: European Urology.Research output: Contribution to journal › Review article › peer-review
Open Access -
Comparative Effectiveness of Bacillus Calmette-Guérin and Sequential Intravesical Gemcitabine and Docetaxel for Treatment-naïve Intermediate-risk Non–muscle-invasive Bladder Cancer
Kolanukuduru, K. P., Ben-David, R., Lidagoster, S., Almoflihi, M., Tillu, N., Eraky, A., Alerasool, P., Waigankar, N., Attalla, K., Mehrazin, R., Wiklund, P. & Sfakianos, J. P., 2024, (Accepted/In press) In: European Urology Focus.Research output: Contribution to journal › Article › peer-review
Press/Media
-
Imaging study offers insights on mechanism behind BCG resistance in NMIBC
22/09/24
1 item of Media coverage
Press/Media
-
Tilray Brands slumps 20% in past year, underperforming 81% of the market
Kaplan, S. & Sfakianos, J.
5/08/24
1 item of Media coverage
Press/Media
-
Monthly: Tilray Brands (TLRY: $2.03) soars 22% on weak volume in July 2024
Kaplan, S. & Sfakianos, J.
1/08/24
1 item of Media coverage
Press/Media
-
Monthly: Tilray Brands (TLRY: $2.03) up 22% on weak volume in July 2024
Kaplan, S. & Sfakianos, J.
31/07/24
1 item of Media coverage
Press/Media